In Situ Peptide-MHC-II Tetramer Staining of Antigen-Specific CD4+ T Cells in Tissues

Area of Science:

• Immunology
• Cell Biology
• T Cell Biology

Background:

• Peptide-MHC-tetramer technology has significantly advanced the study of T lymphocyte biology.
• Visualizing antigen-specific T cells within tissues is crucial for understanding immune responses.
• Existing methods for in situ staining of CD4+ T cells using MHC class II reagents are being complemented.

Purpose of the Study:

• To develop and optimize an in situ peptide-MHC-II tetramer staining method.
• To visualize antigen-specific CD4+ T cells directly within tissues.
• To assess the applicability of this method for studying T cell localization and phenotype in situ.

Main Methods:

• Development of an in situ peptide-MHC-II tetramer staining protocol.
• Utilized group A Streptococcus (GAS) expressing a surrogate peptide (2W) to inoculate C57BL/6 mice.
• Optimized staining using fresh nasal-associated lymphoid tissues (NALT) to detect 2W:I-Ab specific CD4+ T cells.

Main Results:

• Successfully visualized 2W:I-Ab tetramer-binding CD4+ T cells in the nasal-associated lymphoid tissues of mice infected with GAS-2W.
• No tetramer-binding CD4+ T cells were detected in mice infected with GAS alone.
• Demonstrated the specificity of the in situ staining method for antigen-specific CD4+ T cells.

Conclusions:

• The developed in situ pMHC-II tetramer staining method enables visualization of antigen-specific CD4+ T cells in undisrupted tissues.
• This technique offers a valuable tool for studying the localization, abundance, and phenotype of antigen-specific CD4+ T cells.
• The method shows broad applicability for immunological research involving tissue-resident T cells.